Flagship Pioneering, LLC Long-Term Concentrated

Location: Cambridge, MA

CIK: 0001400240 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value: $2.655B (100.0% shares, 0.0% debt)

Holdings (12)

MRNA Moderna Inc 69.3%

Value $1.841B Shares 12,886,743 Est. Cost $16.43 Unrealized +769.8%

SANA Sana Biotechnology Inc 8.3%

Value $220M Shares 34,239,018 Est. Cost $32.56 Unrealized -80.4%

FHTX Foghorn Therapeutics Inc 6.5%

Value $172M Shares 12,674,120 Est. Cost $19.16 Unrealized -32.6%

— Evelo Biosciences Inc 4.0%

Value $106M Shares 50,427,328 Est. Cost $5.89 Unrealized —

— Omega Therapeutics Inc 3.7%

Value $98.43M Shares 25,902,269 Est. Cost $18.85 Unrealized —

DNLI Denali Therapeutics Inc 2.9%

Value $77.11M Shares 2,619,968 Est. Cost $17.97 Unrealized +45.8%

— Seres Therapeutics Inc 1.9%

Value $49.32M Shares 14,378,802 Est. Cost $8.55 Unrealized —

— Axcella Health Inc 1.4%

Value $38.3M Shares 18,867,785 Est. Cost $6.29 Unrealized —

— Rubius Therapeutics Inc 1.2%

Value $32.73M Shares 38,506,526 Est. Cost $24.00 Unrealized —

— Sigilon Therapeutics Inc 0.3%

Value $8.608M Shares 10,370,369 Est. Cost $48.03 Unrealized —

— Codiak Biosciences Inc 0.3%

Value $7.51M Shares 2,607,303 Est. Cost $32.30 Unrealized —

— Syros Pharmaceuticals Inc 0.1%

Value $2.821M Shares 2,938,494 Est. Cost $13.87 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
MRNA	Moderna Inc	12,886,743	$1.841B	69.3%	$16.43	+769.8%	COM	60770K107
SANA	Sana Biotechnology Inc	34,239,018	$220M	8.3%	$32.56	-80.4%	COM	799566104
FHTX	Foghorn Therapeutics Inc	12,674,120	$172M	6.5%	$19.16	-32.6%	COM	344174107
—	Evelo Biosciences Inc	50,427,328	$106M	4.0%	$5.89	—	COM	299734103
—	Omega Therapeutics Inc	25,902,269	$98.43M	3.7%	$18.85	—	COM	68217N105
DNLI	Denali Therapeutics Inc	2,619,968	$77.11M	2.9%	$17.97	+45.8%	COM	24823R105
—	Seres Therapeutics Inc	14,378,802	$49.32M	1.9%	$8.55	—	COM	81750R102
—	Axcella Health Inc	18,867,785	$38.3M	1.4%	$6.29	—	COM	05454B105
—	Rubius Therapeutics Inc	38,506,526	$32.73M	1.2%	$24.00	—	COM	78116T103
—	Sigilon Therapeutics Inc	10,370,369	$8.608M	0.3%	$48.03	—	COM	82657L107
—	Codiak Biosciences Inc	2,607,303	$7.51M	0.3%	$32.30	—	COM	192010106
—	Syros Pharmaceuticals Inc	2,938,494	$2.821M	0.1%	$13.87	—	COM	87184Q107